Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group.

Debiec-Rychter, M; Dumez, H; Judson, I; Wasag, B; Verweij, J; Brown, M; Dimitrijevic, S; Sciot, R; Stul, M; Vranck, H

doi:10.1016/j.ejca.2003.11.025

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group.

NobleIDNI3P59W62R96S40

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C77C49BA.svg?ark=w1%2F20260515%2FC77C49BA&value=id)](https://nobleid.org/work/w1/20260515/C77C49BA)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group.

NobleIDNI3P59W62R96S40

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C77C49BA.svg?ark=w1%2F20260515%2FC77C49BA&value=id)](https://nobleid.org/work/w1/20260515/C77C49BA)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work